brello health semaglutide Review 2025: GLP-1 Telehealth Weight Loss Program With Semaglutide, Tirzepatide, and Personalized Coaching Brello Health Review: Compounded GLP-1

A simple blood test can assess hormone levels, and your provider can evaluate whether semaglutide and/or HRT is right for you

July 10, 2023

Let us help you find the best path toward your weight and health goals

Quick answer: In head-to-head trials, tirzepatide (a dual GLP-1/GIP receptor agonist) produced greater weight loss than semaglutide (a single GLP-1 agonist) 20.2% vs 13.7% over 72 weeks in SURMOUNT-5 though semaglutides single-pathway selectivity keeps it valuable in research

Patients and healthcare providers are encouraged to confirm the authenticity of their prescriptions because of the possible distribution of counterfeit 1-milligram Ozempic injections outside the authorized supply chain